Financhill
Back

Checkpoint Therapeutics Quote, Financials, Valuation and Earnings

Sell
41

CKPT
Checkpoint Therapeutics

Last Price:
1.91
Seasonality Move:
-9.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Checkpoint Therapeutics Price Quote

$1.91
+0.01 (+1.06%)
(Updated: June 1, 2024 at 5:42 AM ET)

Checkpoint Therapeutics Key Stats

Sell
41
Checkpoint Therapeutics (CKPT) is a Sell

Day range:
$1.84 - $1.93
52-week range:
$1.30 - $3.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
443.00
P/B ratio:
0%

Volume:
155.4K
Avg. volume:
404.2K
1-year change:
-28.03%
Market cap:
$70M
Revenue:
$103K
EPS:
$-2.77

How Much Does Checkpoint Therapeutics Make?

Data Unavailable

Is Checkpoint Therapeutics Growing As A Company?

Data Unavailable

Checkpoint Therapeutics Stock Price Performance

What Is Checkpoint Therapeutics 52-Week High & Low?

Checkpoint Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Checkpoint Therapeutics?

Is Checkpoint Therapeutics Cash Flow Positive?

  • What Is CKPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$40M
  • What Is Checkpoint Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $46.4M
  • What Is Checkpoint Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Checkpoint Therapeutics Return On Invested Capital

Data Unavailable

Checkpoint Therapeutics Earnings Date & Stock Price

Checkpoint Therapeutics Competitors

Checkpoint Therapeutics Dividend Yield

Data Unavailable

Checkpoint Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 17.25
Upside from Last Price: 807.89%

Major Shareholders

  • How many CKPT shares are owned by institutional investors?
    9.6M CKPT shares are owned by institutional investors
  • How many CKPT shares are owned by insiders?
    727.2K CKPT shares are owned by insiders